Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN62749026) titled 'A study to investigate if Levodopa (a Parkinson's medication) can help people with wet age-related macular degeneration' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment, Safety
Primary Sponsor: Belfast Health and Social Care Trust
Condition:
Neovascular Age-related Macular Degeneration (nAMD)
Eye Diseases
Intervention:
* Levodopa 100mg / carbidopa 25mg - Active Arm
100mg L-DOPA+25mg carbidopa, orally, twice daily (morning and evening), in addition to the standard of care ant...